The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation
FDA Law Blog
SEPTEMBER 29, 2021
A growing list of drug manufacturers are claiming that the discounts meant for low-income patients of 340B covered entities are instead contributing to profits for pharmacies that contract with covered entities to dispense 340B drugs.
Let's personalize your content